Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Hazel M. Aker currently holds 46,987 shares of CANCERVAX CORP (CNVX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hazel M. Aker has been a net seller of CNVX stock. They have purchased $99.9K and sold $639.7K worth of shares.
Hazel M. Aker's most recent insider trade was on Jul 21, 2020, when they purchased 41,972 shares at $2.38 per share.
Hazel M. Aker serves as Executive at CANCERVAX CORP (CNVX). They have executed 17 insider transactions totaling $739.6K over their tenure at the company.
Hazel M. Aker holds the position of Executive at CANCERVAX CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Hazel M. Aker has shown a selling trading pattern, with $99.9K in total purchases and $639.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Hazel M. Aker was on Nov 15, 2013, when they sold $203.3K worth of CADX shares. This transaction involved 26,028 shares at $7.81 per share.
Hazel M. Aker currently owns 46,987 shares of CANCERVAX CORP (CNVX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Hazel M. Aker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Hazel M. Aker has 17 Form 4 filings on record as an insider at CANCERVAX CORP.
Set alerts for Hazel M. Aker and 40,000+ other insiders.